These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3149736)

  • 41. Fast anterograde axonal transport in wasted and non-wasted diabetic rats; effects of aldose reductase inhibition.
    Whiteley SJ; Townsend J; Tomlinson DR; Willars GB
    Diabetes Res; 1986 Nov; 3(9):447-52. PubMed ID: 2435444
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of aldose reductase in five tissues of the streptozotocin-diabetic rat.
    Poulsom R; Heath H
    Biochem Pharmacol; 1983 May; 32(9):1495-9. PubMed ID: 6407486
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Studies on peripheral nerve and lens in long-term experimental diabetes: effects of the aldose reductase inhibitor statil.
    Willars GB; Townsend J; Tomlinson DR; Compton AM; Churchill RD
    Metabolism; 1988 May; 37(5):442-9. PubMed ID: 2452959
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of aldose reductase inhibitor on retinal microangiopathy in streptozotocin-diabetic rats.
    Kojima K; Matsubara H; Harada T; Mizuno K; Suzuki M; Hotta N; Kakuta H; Sakamoto N
    Jpn J Ophthalmol; 1985; 29(1):99-109. PubMed ID: 3159927
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Altering the course of cataracts in diabetic rats.
    Fukushi S; Merola LO; Kinoshita JH
    Invest Ophthalmol Vis Sci; 1980 Mar; 19(3):313-5. PubMed ID: 6766909
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adenosine triphosphatase in nerves and ganglia of rats with streptozotocin-induced diabetes or galactosaemia; effects of aldose reductase inhibition.
    Lambourne JE; Brown AM; Calcutt N; Tomlinson DR; Willars GB
    Diabetologia; 1988 Jun; 31(6):379-84. PubMed ID: 2970984
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development of potent aldose reductase inhibitors having a hydantoin structure.
    Miwa I; Hirano M; Inagaki K; Belbeoc'h C; Okuda J
    Biochem Pharmacol; 1987 Sep; 36(17):2789-94. PubMed ID: 3115267
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of aldose reductase inhibitor sorbinil on neuroaxonal dystrophy and levels of myo-inositol and sorbitol in sympathetic autonomic ganglia of streptozocin-induced diabetic rats.
    Schmidt RE; Plurad SB; Sherman WR; Williamson JR; Tilton RG
    Diabetes; 1989 May; 38(5):569-79. PubMed ID: 2497038
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Glucose-induced microvascular functional changes in nondiabetic rats are stereospecific and are prevented by an aldose reductase inhibitor.
    Williamson JR; Ostrow E; Eades D; Chang K; Allison W; Kilo C; Sherman WR
    J Clin Invest; 1990 Apr; 85(4):1167-72. PubMed ID: 2108189
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Properties of ICI 128,436, a novel aldose reductase inhibitor, and its effects on diabetic complications in the rat.
    Stribling D; Mirrlees DJ; Harrison HE; Earl DC
    Metabolism; 1985 Apr; 34(4):336-44. PubMed ID: 3920474
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Muscarinic receptor density is reduced in diabetic rat atria, an effect prevented by the aldose reductase inhibitor, Statil.
    Kofo-Abayomi A; Lucas PD
    J Pharm Pharmacol; 1987 Dec; 39(12):1019-21. PubMed ID: 2894428
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reversal of proteinuria by sorbinil, an aldose reductase inhibitor in spontaneously diabetic (BB) rats.
    Beyer-Mears A; Murray FT; Del Val M; Cruz E; Sciadini M
    Pharmacology; 1988; 36(2):112-20. PubMed ID: 3127836
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of an aldose reductase inhibitor, ONO-2235, insulin and their combination on the altered responsiveness to the nerve stimulation and agonists of the isolated atria of diabetic rats.
    Hashimoto H; Satoh N; Takiguchi Y; Nakashima M
    J Pharmacol Exp Ther; 1990 May; 253(2):552-7. PubMed ID: 2159998
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of long-term aldose reductase inhibition on development of experimental diabetic neuropathy. Ultrastructural and morphometric studies of sural nerve in streptozocin-induced diabetic rats.
    Yagihashi S; Kamijo M; Ido Y; Mirrlees DJ
    Diabetes; 1990 Jun; 39(6):690-6. PubMed ID: 2140802
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Stimulation of glucosylated lens epithelial Na,K-ATPase by an aldose reductase inhibitor.
    Garner MH; Wang GM; Spector A
    Exp Eye Res; 1987 Aug; 45(2):339-45. PubMed ID: 2820775
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Aldose reductase inhibition and glomerular abnormalities in diabetic rats.
    Daniels BS; Hostetter TH
    Diabetes; 1989 Aug; 38(8):981-6. PubMed ID: 2502460
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Direct stimulation of Na+-K+-ATPase and its glucosylated derivative by aldose reductase inhibitor.
    Garner MH; Spector A
    Diabetes; 1987 Jun; 36(6):716-20. PubMed ID: 3032716
    [TBL] [Abstract][Full Text] [Related]  

  • 58. No influence of an aldose reductase inhibitor on glycogen deposition in tubules from streptozotocin diabetic rats.
    Rasch R; Osterby R
    J Diabet Complications; 1989; 3(4):198-201. PubMed ID: 2533211
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tolrestat, an aldose reductase inhibitor, prevents nerve dysfunction in conscious diabetic rats.
    Notvest RR; Inserra JJ
    Diabetes; 1987 Apr; 36(4):500-4. PubMed ID: 3102300
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of polyol pathway activity in diabetic and galactosemic rats by the aldose reductase inhibitor CP-45,634.
    Peterson MJ; Sarges R; Aldinger CE; MacDonald DP
    Adv Exp Med Biol; 1979; 119():347-56. PubMed ID: 115231
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.